Trial intelligence / Profile preview

Dexmedetomidine nasal spray for postoperative sleep after video-assisted thoracoscopic surgery

ChiCTR2500099569Phase 4Not yet recruiting

Sponsor
The Affiliated Hospital of Xuzhou Medical University
Start
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dexmedetomidine in sleep disorder (3 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Incidence of sleep disorder on the night of operation. Planned start Mar 2025; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

sleep disorder

Beyond the preview

Go deeper on ChiCTR2500099569.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500099569.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call